Disclaimer

TAPS Approval No: PP2968
Advertisement Title: Louise Highet Aesthetics Website
Client: Louise Highet Aesthetics
Product: Website
This Advertisement is approved in accordance with TAPS Guidelines and Procedures. Please also see (over) the
accompanying terms and conditions of the TAPS service.
Adjudicator Signature: Peter Pratt
Approval Issue Date: 15 August 2024

According to the Medicines Act 1981 and the NZ Advertising Standards Authority, any organization promoting the use of Botox®, Xeomin®, Dysport®, Profhilo® Radiesse® are required to display the following mandatories. Botox®,  Prescription Medicine.

Botox®,  Prescription Medicine.

Botox® is a prescription medicine for the treatment of frown lines , horizontal forehead lines and crow’s feet round the eyes and excessive sweating under the arms. Botox® has risks and benefits. Ask your specialist if Botox is right for you. If you have side effects see your doctor. You will need to pay for Botox® and clinic fees will apply. For details on precautions & side effects consult your healthcare professional or the Consumer Medicine Information (CMI) at www.medsafe.govt.nz . Botox® treatment lasts about 4 months and further courses of treatment may be necessary. (contains botulinum toxin A 50,100 & 200 units) Abbvie Ltd, Wellington.

Xeomin®

Xeomin® is a Prescription Medicine containing 50, 100 units of incobotulinum Type A, purified Botulinum toxin type A complex for injection. It is used for the treatment of frown lines on the forehead, lateral periorbital lines and horizontal forehead lines in adults. It should be administered only by trained medical professionals. Talk to your specialist about the benefits/risks of this procedure in appearance medicine. Xeomin treatment lasts about four months and further courses of treatment may be necessary. Cautions: people receiving blood thinning medicines, care at the proposed injection sites, pregnancy and lactation. Possible side effects: headache, pain, swelling or infection at injection site, local muscle weakness including drooping eye lids, lack of feeling & nausea. You will need to pay for this medicine. Discuss with your specialist if Xeomin is right for you.

For more information or for a copy of CMI please contact the NZ distributor: NZMS Ltd: 2a Fisher Crescent, Mt Wellington, Auckland, Ph 09 259 4062.

DYSPORT®

DYSPORT® (Clostridium botulinum type A toxin-haemagglutinin complex, 500 IPSEN units) is a Prescription Medicine for the treatment of vertical frown lines between the eyebrows, and excessive underarm sweating. It should be administered only by trained medical professionals. DYSPORT® has risks and benefits. For more information, talk to your healthcare professional or read the Consumer Medicine Information available at www.medsafe.govt.nz. Ask your specialist if DYSPORT® is right for you. Always follow your specialist’s instructions. If you experience side effects and they concern you, see your healthcare professional. You will need to pay for DYSPORT® and for the administration and consultation charges. Galderma c/o Healthcare Logistics 58 Richard Pearse Drive Airport Oaks, Auckland, New Zealand.

BELKYRA®

BELKYRA® injection (deoxycholic acid 10 mg/mL) is a Prescription Medicine used for the improvement in the appearance of moderate to severe convexity or fullness associated with submental fat in adults. It should be administered only by trained medical professionals. BELKYRA® has risks and benefits. For more information, talk to your healthcare professional or read the Consumer Medicine Information available at www.medsafe.govt.nz. Ask your specialist if BELKYRA® is right for you. Always follow your specialist’s instructions. If you experience side effects and they concern you, see your healthcare professional. You will need to pay for BELKYRA®. Normal Doctors visit fees apply. BELKYRA® treatment should be administered only by trained medical professionals. Speak to your specialist about your own situation and about the benefits/risks of this procedure in appearance medicine.. Note: Results from BELKYRA® treatment usually last up to four years.

BELKYRA® and its design are trademarks of Kythera Biopharmaceuticals, Inc., an Allergan affiliate. ™Trademark of Allergan, Inc. Allergan Australia Pty Ltd, 810 Pacific Highway, Gordon NSW 2072. ABN 85 000 612 831. Allergan New Zealand Limited, Auckland. © 2018 Allergan.

RADIESSE® and RADIESSE® (+)

RADIESSE® and RADIESSE® (+) are dermal fillers that are used for smoothing moderate to severe facial wrinkles and folds, such as nasolabial folds (the creases that extend from the corner of your nose to the corner of your mouth). RADIESSE® is also used for correcting volume loss in the back of the hands.

RADIESSE® and RADIESSE® (+) IMPORTANT SAFETY INFORMATION

Q: Who should not use RADIESSE® or RADIESSE® (+)?

A: You should not use RADIESSE® or RADIESSE® (+) if you have an allergy to any component of the product, if you have a history of severe allergies, if you have a bleeding disorder, or if you are pregnant or breastfeeding.

You should not use RADIESSE® (+) if you have an allergy to lidocaine or medicines like it.

Q: What is the most important information I should know about RADIESSE® and RADIESSE® (+)?

A: One of the risks with using these products is unintentional injection into a blood vessel. The chances of this happening are very small, but if it does happen, the complications can be serious, and may be permanent. These complications, which have been reported for facial injections, can include vision abnormalities, blindness, stroke, temporary scabs, or permanent scarring of the skin. If you have changes in your vision, signs of a stroke (including sudden difficulty speaking, numbness or weakness in your face, arms, or legs, difficulty walking, face drooping, severe headache, dizziness, or confusion), white appearance of the skin, or unusual pain during or shortly after treatment, you should notify your health care practitioner immediately.

As with all procedures that involve an injection through the skin, there is a risk of infection.

  • Do not use RADIESSE® or RADIESSE® (+) if you have a skin infection until it has healed.
  • It is not known if RADIESSE® or RADIESSE® (+) is safe or effective in the lips, or in the area around the eyes.
  • The microspheres in RADIESSE® and RADIESSE® (+) can be seen in X-rays and CT Scans. It is very important that you tell your health care provider that you have had RADIESSE® or RADIESSE® (+) dermal filler.
  • If you have a history of herpes, you may experience a herpes breakout after receiving RADIESSE® or RADIESSE® (+).
  • Injection in the back of the hand may result in temporary difficulty performing activities. RADIESSE® may cause nodules, bumps or lumps in the back of the hand and can last up to 1 year.

You should minimize strenuous activity and avoid extensive sun or heat exposure for about 24 hours after treatment and until any swelling or redness has resolved.

Q: What should I tell my doctor before using RADIESSE® or RADIESSE®?

A: Tell your health care provider if you are taking blood thinners or medicines that can interfere with the clotting of blood, such as aspirin or warfarin. These medicines might make it more likely that you will experience bruising or bleeding at the injection site. Tell your health care provider if you have any diseases, injuries or disabilities of the hand, if you have a history forming large, raised scars or if you have had any other skin treatments such as skin peels.

Q: What are the most common adverse events with RADIESSE® or RADIESSE®?

A: The most common adverse events seen in clinical studies of RADIESSE® used in the hands include bruising, redness, swelling, pain, itching, nodules or bumps/lumps, difficulty performing activities, loss of sensation and other local side effects. The most common adverse events seen in clinical studies of RADIESSE® or RADIESSE® (+) used in the face include bruising, redness, swelling, pain, itching and other local side effects. These are not all of the possible side effects with RADIESSE® or RADIESSE® (+). Merz collects information about adverse events seen with RADIESSE® and RADIESSE® (+) outside of clinical studies. These events are included in the RADIESSE® and RADIESSE® (+) Patient

Information Guide based on an assessment of seriousness and potential causal relationship to RADIESSE® or RADIESSE® (+). Please see the Patient Information Guide available at www.radiesse.com for list of these events. Tell your health care provider about any side effects that bother you or do not go away.

Important: For full safety information, please visit www.Radiesse.com
or call MyMerz Solutions at 1-844-469-6379
RADIESSE® and RADIESSE® (+) are available by prescription only.

TEOSYAL SA

TEOSYAL SA, TEOSYAL RHA® 1, TEOSYAL  RHA® 2, TEOSYAL RHA® 3, TEOSYAL RHA® 4, TEOSYAL® PURESENSE REDENSITY 1, TEOSYAL® PURESENSE REDENSITY 2, TEOSYAL PURESENSE KISS ®, TEOSYAL® PURESENSE GLOBAL ACTION, TEOSYAL® PURESENSE DEEP LINES, TEOSYAL® PURESENSE ULTIMATE and TEOSYAL® PURESENSE ULTRA DEEP are trademark of the firm TEOXANE SA. These products are gel that contains hyaluronic acid, and 0.3% by weight of lidocaine hydrochloride (local anesthetic can induce a positive reaction to anti-doping tests). In the case of known hypersensitivity to lidocaine and/or amide local anaesthetic agents, we recommend not use lidocaine-containing products and please refer to products without lidocaine. They are class III medical device and are regulated health product bearing the CE marking (CE2797) under this regulation. Local manifestations: inflammatory reactions (erythema, oedema, pain at the point of injection), haematomas, itching, temporary loss of sensitivity around the injected area, dyschromia, abscesses, indurations, nodules (possibly granulomas). General manifestations: immediate hypersensitivity up to anaphylactic shock, migration of the implant.

Rare but serious adverse events associated with the intravascular injection of soft tissue fillers in the face have been reported and include temporary or permanent vision impairment or blindness,skin necrosis and stroke. Please consult your physician or pharmacist for more information.

Profhilo®

Profhilo® containing low & high molecular weight hyaluronic acid, is a Class III Medical Device for the treatment of the face and body for contours redefinition and laxity remodelling where skin laxity is a problem.⁠ Profhilo has risks and benefits.⁠ Do not use with treatments such as laser resurfacing or medium deep skin-peeling. Do not inject into inflamed areas or intravenously or intramuscularly. Possible side effects: pain and swelling at injection site .

Accelagen Pty Ltd. Whanganui

BELOTERO®

BELOTERO® Revive is an injectable Class III medical device intended to treat early signs of photodamaged skin via rehydration of dry and very dry skin and smoothening of superficial fine lines. BELOTERO® Revive has benefits & risks. Ask your healthcare professional if BELOTERO® Revive is right for you and to explain side effects. Precautions: Bleeding disorders, keloid scars, general infection, autoimmune disease. Tell your specialist if you have side effects. Use strictly as directed. This medical device must be administered by a healthcare professional. For further information please phone 0800 822 310. Unfunded in NZ. Merz Australia. Distributed by Healthcare Logistics, Auckland. TAPS MR10377. May 2024.